Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18698359 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed AMA1-C1/Alhydrogel + CpG 7909 for Malaria
Condition: Plasmodium Falciparum Malaria
Interventions: Biological: AMA1-C1/Alhydrogel®;   Biological: CPG 7909 Oligodeoxynucleotide (VaxImmune®)

Study has passed its completion date and status has not been verified in more than two years.